F&P sees ‘continued strong performance’ for masks 

AUCKLAND, New Zealand – Fisher & Paykel Healthcare has reported record revenue of $359.4 million for its Homecare product group for the first half of the 2025 financial year, a 14% increase. 

Sales of masks and accessories for treating obstructive sleep apnea increased 14% in constant currency.  

“We are pleased with the continued strong performance of our range of masks for patients with obstructive sleep apnea,” said Lewis Gradon, managing director and CEO. “With the introduction of the F&P Nova Micro mask, alongside our recently launched F&P Solo AutoFit mask and F&P Evora Full, we address a diverse array of patient needs and preferences with our latest technology.” 

F&P reported total operating revenue of $951.2 million for the first half of the 2025 financial year, an 18% increase. It reported net profit after tax of $153.2 million, a 43% increase.  

The company also reported a gross margin of 61.9%, a 141-basis-point increase in reported currency. 

F&P is sticking with its full-year guidance of operating revenue in the range of about $1.9 billion to $2 billion and full-year net profit after tax in the range of about $320 million to $370 million. 

Here’s an overview of the company’s financial results: 

• 18% increase in operating revenue to $951.2 million, 17% increase in constant currency. 
• 43% increase in net profit after tax to $153.2 million, 51% increase in constant currency. 
• 21% increase in Hospital operating revenue to $591.4 million, 21% increase in constant currency. 
• 24% increase in constant currency for new applications consumables (products used in noninvasive ventilation, Optiflow nasal high flow and surgical applications) accounting for 73% of Hospital consumables revenue. 
• 14% increase in Homecare operating revenue to $359.4 million, 13% increase in constant currency. 
• 14% increase in constant currency for OSA masks and accessories revenue. 
• Investment in R&D was 12% of revenue, or $110.1 million. 
• 3% increase in interim dividend to 18.5 cps (H1 FY24: 18 cps).